1. Home
  2. ICUCW vs VCEL Comparison

ICUCW vs VCEL Comparison

Compare ICUCW & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SeaStar Medical Holding Corporation Warrant

ICUCW

SeaStar Medical Holding Corporation Warrant

N/A

Current Price

$0.01

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$36.24

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICUCW
VCEL
Founded
N/A
1989
Country
United States
United States
Employees
18
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.0B
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
ICUCW
VCEL
Price
$0.01
$36.24
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$60.40
AVG Volume (30 Days)
N/A
611.4K
Earning Date
N/A
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
N/A
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
N/A
$18.55
P/E Ratio
N/A
$147.60
Revenue Growth
N/A
14.05
52 Week Low
N/A
$29.24
52 Week High
N/A
$63.00

Technical Indicators

Market Signals
Indicator
ICUCW
VCEL
Relative Strength Index (RSI) 37.89 45.15
Support Level $0.01 $34.79
Resistance Level $0.01 $37.11
Average True Range (ATR) 0.00 1.42
MACD 0.00 -0.30
Stochastic Oscillator 33.33 28.10

Price Performance

Historical Comparison
ICUCW
VCEL

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: